Ragosa Mark bought KNSA

December 8, 2025 · Form 4 insider transaction

Ragosa Mark bought 16,165 shares of Kiniksa Pharmaceuticals Ltd. at $11.97 per share, a transaction worth $193.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

16,165

Price

$11.97

Total value

$193.5K

InsiderRagosa Mark

RoleOfficer

CompanyKiniksa Pharmaceuticals Ltd. (KNSA)

SecurityClass A Ordinary Share

Transaction codeM — Option exercise

Transaction dateDecember 8, 2025

Filing dateDecember 10, 2025

Shares owned after63,415

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

View the original Form 4 on SEC EDGAR